Januvia Jitters: FDA Warns Blockbuster Diabetes Drug May Cause Pancreatitis
Scrutiny of Merck’s Januvia could raise more questions about Onglyza and other DPP-4 inhibitors.
Scrutiny of Merck’s Januvia could raise more questions about Onglyza and other DPP-4 inhibitors.